Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of SPECT in Radiotherapy Treatment Planning and Toxicity Evaluation for the Patients With Stage I-III NSCLC

NCT01745484 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT01745484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of SPECT in Radiotherapy Treatment Planning and Toxicity Evaluation for the Patients With Stage I-III NSCLC
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2012
Completion date
July 31, 2015
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer, radiation pneumonitis